mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management
ACS Nano · 22.08.2023 · 17 (16) · 15724-15741
DOI: 10.1021/acsnano.3c03232 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 11.08.2023. Verfasst von Fan Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Tianjin University, Tianjin 300072, P. R. China. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin City, National Natural Science Foundation of China, Tianjin Key Medical Discipline (Specialty) Construction Project.
Themen: Demenz
Abstract (Originalsprache)
Metabolic reprogramming that senses brain homeostasis imbalances is necessary to drive detrimental microglial polarization, and specific targeting of this process contributes to the flexible control of pathological inflammatory responses in Alzheimer's disease (AD), displaying distinctive therapeutic benefits. Herein, glutathione-functionalized gold nanocages loaded with the immunosuppressant fingolimod hydrochloride are developed as brain-targeted and microglia-located immunometabolic reprogramming nanomodulators (GAF NPs) for AD management. By virtue of glutathione-mediated transport properties, this nanomodulator can cross the blood-brain barrier and localize to microglia in AD lesions. Through blocking Akt/mTOR/HIF-1α signaling pathways, GAF NPs not only promote the dominated metabolic shift from glycolysis to oxidative phosphorylation under immune activation but also inhibit transporter-mediated glucose overconsumption by microglia. Correlation analysis based on real-time bioenergetic assessment and 18F-labeled fluorodeoxyglucose (FDG) PET reveals that brain glucose utilization and metabolism restored by GAF NP treatment can serve as a sensitive and effective indicator for microglial M1 to M2 polarization switching, ultimately alleviating neuroinflammation and its derived neurodegeneration as well as ameliorating cognitive decline in AD mice. This work highlights a potential nanomedicine aimed at modifying mTOR-mediated immunometabolic reprogramming to halt energy deprivation-induced AD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Tianjin University, Tianjin 300072, P. R. China.
- Department of Radiology and Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University General Hospital, Tianjin 300052, P. R. China.
ORCID-Profile: Dongju Zhao, Jin Chang, Yan Dou
Förderung
- Natural Science Foundation of Tianjin City
- National Natural Science Foundation of China
- Tianjin Key Medical Discipline (Specialty) Construction Project
Zitieren
APA
Yang, F., Zhao, D., Cheng, M., Liu, Y., Chen, Z., Chang, J., & Dou, Y. (2023). mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management. ACS Nano, 17(16), 15724-15741. https://doi.org/10.1021/acsnano.3c03232
Vancouver
Yang F, Zhao D, Cheng M, Liu Y, Chen Z, Chang J, et al. mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management. ACS Nano. 2023;17(16):15724-15741. doi:10.1021/acsnano.3c03232
BibTeX
@article{Yang2023,
author = {Yang, Fan and Zhao, Dongju and Cheng, Meng and Liu, Yining and Chen, Ziyao and Chang, Jin and Dou, Yan},
title = {mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management},
journal = {ACS Nano},
year = {2023},
volume = {17},
number = {16},
pages = {15724--15741},
doi = {10.1021/acsnano.3c03232}
}
EUVIMED